Botox is an injectable protein that temporarily relaxes small facial muscles, reliably smoothing movement lines between the brows, around the eyes, and across the forehead. Repeated use may soften resting lines and improve skin texture, though this is less certain. Effects last 3–4 months. Side effects are usually mild and depend on injector skill. (Full Review)

Protocol

Standard Glabellar

~20 units, 5 points

Corrugator and procerus muscles between and above the brows

Crow's Feet & Forehead

~12 units/side; ~10–20 units

Orbicularis oculi per side; frontalis conservatively, balanced against the glabella

Re-treatment Cadence

Every 3–4 months

Given as a single set of injections per session; intervals may lengthen over time

Time to effect

Onset

2–7 days

Results are not immediate

Peak Effect

~2 weeks

Best timed at least two weeks before any desired event

Duration

~3–4 months

Functional duration governs re-treatment intervals

Benefits

High: Reduction of dynamic glabellar lines; reduction of lateral canthal lines; reduction of horizontal forehead lines

Medium: Softening of static lines over repeated treatment; improvement in skin quality and pore appearance

Low: Prevention or delay of new expression lines; improvement in skin elasticity and collagen markers

Speculative: Adjunctive enhancement of wound healing and scar quality; mood-mediated feedback effects on perceived facial aging

Contraindications

Known hypersensitivity to botulinum toxin or formulation components

Neuromuscular disorders (myasthenia gravis, Lambert-Eaton myasthenic syndrome, amyotrophic lateral sclerosis)

Active infection at the intended injection site

Pregnancy or breastfeeding

Key Interactions

Aminoglycoside and other neuromuscular-affecting antibiotics (gentamicin, tobramycin, streptomycin)

Neuromuscular blocking agents and muscle relaxants (succinylcholine, tubocurarine, baclofen, dantrolene)

Anticholinergic drugs (oxybutynin, some antihistamines and tricyclic antidepressants)

Over-the-counter agents that increase bleeding (aspirin, ibuprofen and other NSAIDs, high-dose fish oil)

Supplements with blood-thinning or additive effects (fish oil/omega-3, vitamin E, ginkgo, garlic, ginger)

Other injectable or energy-based treatments (dermal fillers, laser, microneedling)

Risk & Side Effects

High: Injection-site reactions; headache

Medium: Eyelid or brow ptosis; asymmetry and unnatural expression

Low: Dry eye, excess tearing, or diplopia; antibody-mediated reduced response

Speculative: Distant spread and systemic botulism-like effects; long-term muscle atrophy or skin thinning

Monitoring

Marker	Target	Why
Platelet count	150–400 ×10⁹/L	Screens bleeding/bruising risk
INR (international normalized ratio)	<1.2 (untreated); at target if on anticoagulants	Assesses clotting to gauge bruising risk
Acetylcholine receptor antibodies	Negative	Screens for myasthenia gravis before treatment
Vitamin D, 25-hydroxy	40–60 ng/mL	Supports overall skin and tissue health

Cadence: Review at 2 weeks after the first treatment, then reassessment at each maintenance visit approximately every 3–4 months, with standardized photography.

Qualitative Assessment

Softening of targeted dynamic lines with movement (frowning, smiling, brow raising)
Preserved natural expression without a "frozen" or heavy-brow appearance
Symmetric brow position and eyelid opening
Subjective satisfaction with skin smoothness, and for microtox, reduced oiliness and smaller-appearing pores
Absence of bruising, ptosis, or headache at follow-up
Consistent duration of effect across cycles (a shortening duration may signal reduced response)

Botox for Skin Rejuvenation

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment